Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02061787

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Chronic Thromboembolic Pulmonary Hypertension Hypertension Hypertension, Pulmonary Lung Diseases Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder) Respiratory Tract Diseases Vascular Diseases

Age range

5 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

center of pulmonary vascular disease, Fuwai hospital

Beijing, 100037, China

Location status: Recruiting

Location contact

Xiuping Ma

CONTACT

[email protected]

8601088396816

Zhihong Liu, MD,PhD

PRINCIPAL_INVESTIGATOR

About this study

patients diagnosed with pulmonary hypertension, including pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, will be evaluated by cardio pulmonary exercise test before and after medical or balloon pulmonary angioplasty treatment

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pulmonary arterial hypertension;( WHO1)
  • chronic thromboembolic pulmonary hypertension;
  • pulmonary arterial hypertension due to other cause;

Exclusion criteria

  • massive hemoptysis;
  • unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
  • recent recurrent syncope;
  • pulmonary hypertension due to hypoxia;
  • pulmonary hypertension due to left heart diseases.

Treatment and study plan

balloon pulmonary angioplasty

Device

patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty

Primary outcomes

  1. all cause mortality

    Time frame: 5 years

    all cause mortality

  2. mean pulmonary arterial pressure after treatment

    Time frame: 5 years

    the mean pulmonary arterial pressure of patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty treatment

  3. achievement of low risk

    Time frame: 5 years

    patients with chronic thromboembolic pulmonary hypertension achievement of low risk after balloon pulmonary angioplasty

Secondary outcomes

  1. deterioration of WHO function

    Time frame: 5 years

    deterioration of WHO function

Study contacts

Contact information is provided by the study sponsor or research team.

Zhihong Liu, Doctor

CONTACT

[email protected]

8601088396590

Sponsors and collaborators

Lead sponsor

Chinese Pulmonary Vascular Disease Research Group

Other

Registry information

Acronym: CPETPH

Important dates

Study start
2010
Primary completion
2030
Study completion
2030
First posted
Feb 13, 2014
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.